Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Sees Significant Growth in Short Interest

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) was the recipient of a large increase in short interest in July. As of July 31st, there was short interest totaling 224,453 shares, an increase of 90.8% from the July 15th total of 117,659 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 613,487 shares, the days-to-cover ratio is currently 0.4 days.

Wall Street Analysts Forecast Growth

Separately, Kepler Capital Markets upgraded Coloplast A/S to a “strong-buy” rating in a research note on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Coloplast A/S presently has a consensus rating of “Hold”.

Get Coloplast A/S alerts:

Check Out Our Latest Stock Analysis on Coloplast A/S

Coloplast A/S Price Performance

OTCMKTS:CLPBY opened at $6.68 on Monday. The stock has a 50-day simple moving average of $6.22 and a 200 day simple moving average of $6.69. Coloplast A/S has a one year low of $5.64 and a one year high of $10.03. The company has a market capitalization of $15.05 billion, a price-to-earnings ratio of 47.71, a price-to-earnings-growth ratio of 2.12 and a beta of 0.13. The company has a debt-to-equity ratio of 1.66, a quick ratio of 1.09 and a current ratio of 1.75.

About Coloplast A/S

(Get Free Report)

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.

Featured Stories

• Five stocks we like better than Coloplast A/S
• 3 Robotics Stocks Under $10: Value, Momentum, or Bet?
• 3 ETFs Built to Protect Your Money if the Bull Market Breaks
• JFrog’s AI Opportunity Could Fuel a Big Leap in Share Price
• Is SiTime the Best AI Stock You’ve Never Heard Of?

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.